v3.26.1
Equity Method and Other Investments (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
May 27, 2026
Mar. 29, 2026
Jan. 26, 2026
Dec. 31, 2025
Aug. 29, 2025
Jul. 28, 2025
Schedule of Equity Method Investments [Line Items]                    
Gain on deconsolidation     $ 19,336,000 $ 0            
Carrying value of investment $ 24,855,000   $ 24,855,000         $ 0    
Preferred stock, par value $ 0.01   $ 0.01         $ 0.01    
IsoBio Inc [Member]                    
Schedule of Equity Method Investments [Line Items]                    
Carrying value of investment $ 5,600,000   $ 5,600,000         $ 5,600,000    
Change in fair value of investment 0   0              
Skyline | Skyline Exchange Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Change in fair value of investment 0 $ 1,100,000 1,100,000              
Decreasing ownership percentage           10.00%        
Carrying value of investment 24,900,000   24,900,000     $ 23,800,000        
Opeongo [Member]                    
Schedule of Equity Method Investments [Line Items]                    
Carrying value of investment 10,000,000   10,000,000              
Change in fair value of investment 0   0              
ENDRA Life Sciences, Inc.                    
Schedule of Equity Method Investments [Line Items]                    
Carrying value of investment 3,800,000   3,800,000              
Change in fair value of investment $ 0   0              
Stock purchase amount         $ 3,800,000          
Class B Ordinary Shares | Skyline | Skyline Stock Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Share purchased                 1,995,000  
Total aggregate purchase price of shares                 $ 1,000,000  
Class B Ordinary Shares | Skyline | Skyline Exchange Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Share purchased           1,995,000        
Gain on deconsolidation     $ 19,300,000              
Class A Ordinary Shares | Skyline | Securities Purchase Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Share purchased                 454,794  
Class A Ordinary Shares | Skyline | Skyline Exchange Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Share owned           1,995,000        
Common Stock [Member] | ENDRA Life Sciences, Inc.                    
Schedule of Equity Method Investments [Line Items]                    
Agreed to purchase ordinary shares         66,846          
Warrant A | Class A Ordinary Shares | Skyline | Securities Purchase Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Exercise price per share                 $ 0.6  
Warrant A | Maximum | Class A Ordinary Shares | Skyline | Securities Purchase Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Common stock shares of warrant agreements                 2,054,794  
Warrant B | Class A Ordinary Shares | Skyline | Securities Purchase Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Exercise price per share                 $ 0.65  
Warrant B | Maximum | Class A Ordinary Shares | Skyline | Securities Purchase Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Common stock shares of warrant agreements                 2,054,794  
Series Seed-1 Preferred Stock | IsoBio Inc [Member]                    
Schedule of Equity Method Investments [Line Items]                    
Share purchased                   2,000,000
Share purchased price per share                   $ 2.5
Total aggregate purchase price of shares                   $ 5,000,000
Series Seed-1 Preferred Stock | Opeongo [Member]                    
Schedule of Equity Method Investments [Line Items]                    
Share purchased price per share             $ 2.2952      
Agreed to purchase ordinary shares             4,356,918      
Stock purchase amount             $ 10,000,000      
Prefunded Warrant | ENDRA Life Sciences, Inc.                    
Schedule of Equity Method Investments [Line Items]                    
Agreed to purchase ordinary shares         511,541          
Prefunded Warrant | Class A Ordinary Shares | Skyline | Securities Purchase Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Share purchased                 1,600,000  
Exercise price per share                 $ 0.0001  
Warrants | Skyline | Skyline Stock Agreement                    
Schedule of Equity Method Investments [Line Items]                    
Total aggregate purchase price of shares                 $ 1,500,000  
Warrants | ENDRA Life Sciences, Inc.                    
Schedule of Equity Method Investments [Line Items]                    
Agreed to purchase ordinary shares         1,156,774